<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Bajorics Balázs &#8211; Ardat</title>
	<atom:link href="https://ardat.org/author/balazsbajorics/feed/" rel="self" type="application/rss+xml" />
	<link>https://ardat.org</link>
	<description>Accelerating R&#38;D for Advanced Therapies</description>
	<lastBuildDate>Thu, 19 Dec 2024 16:28:06 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.5</generator>

<image>
	<url>https://ardat.org/wp-content/uploads/2020/11/cropped-Asset-2-3-32x32.png</url>
	<title>Bajorics Balázs &#8211; Ardat</title>
	<link>https://ardat.org</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Dr Yvonne Katterle presented at the 17th EBF Open Symposium</title>
		<link>https://ardat.org/dr-yvonne-katterle-presented-at-the-17th-ebf-open-symposium/</link>
		
		<dc:creator><![CDATA[Bajorics Balázs]]></dc:creator>
		<pubDate>Thu, 19 Dec 2024 16:28:06 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://ardat.org/?p=10692</guid>

					<description><![CDATA[Dr Yvonne Katterle, Head of Bioanalytics at Bayer presented an update on her ARDAT work on the “Strengths and weaknesses of different ligand binding assay formats for the determination of anti-AAV9 antibodies” at the 17th EBF Open Symposium in Barcelona, Spain 20-22nd November 2024.]]></description>
										<content:encoded><![CDATA[<p>Dr Yvonne Katterle, Head of Bioanalytics at Bayer presented an update on her ARDAT work on the “Strengths and weaknesses of different ligand binding assay formats for the determination of anti-AAV9 antibodies” at the 17<sup>th</sup> EBF Open Symposium in Barcelona, Spain 20-22<sup>nd</sup> November 2024.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Polyfunctional T cells and unique cytokine clusters imprint the anti rAAV2/rAAV9 vector immune response</title>
		<link>https://ardat.org/polyfunctional-t-cells-and-unique-cytokine-clusters-imprint-the-anti-raav2-raav9-vector-immune-response/</link>
		
		<dc:creator><![CDATA[Bajorics Balázs]]></dc:creator>
		<pubDate>Thu, 19 Dec 2024 16:26:55 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://ardat.org/?p=10689</guid>

					<description><![CDATA[We are pleased to report the publication of our recent paper in Frontiers in Immunology. The work provides insights into adaptive immunity with rAAV vector serotypes which will be important in advancing gene therapy safety, vector selection, immunogenicity assessment and better patient selection for AAV gene therapy. Further details about the publication can be accessed &#8230; <p class="link-more"><a href="https://ardat.org/polyfunctional-t-cells-and-unique-cytokine-clusters-imprint-the-anti-raav2-raav9-vector-immune-response/" class="more-link">Read More <span class="screen-reader-text"> "Polyfunctional T cells and unique cytokine clusters imprint the anti rAAV2/rAAV9 vector immune response"</span></a></p>]]></description>
										<content:encoded><![CDATA[<p>We are pleased to report the publication of our recent paper in Frontiers in Immunology. The work provides insights into adaptive immunity with rAAV vector serotypes which will be important in advancing gene therapy safety, vector selection, immunogenicity assessment and better patient selection for AAV gene therapy. Further details about the publication can be accessed via the <a href="https://www.frontiersin.org/articles/10.3389/fimmu.2024.1450524">link</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Dr Bernard Maillere presents at The Festival of Biologics</title>
		<link>https://ardat.org/dr-bernard-maillere-research-director-in-immunology-at-the-french-alternative-energies-and-atomic-energy-commission-cea-presented/</link>
		
		<dc:creator><![CDATA[Bajorics Balázs]]></dc:creator>
		<pubDate>Thu, 05 Dec 2024 07:59:33 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://ardat.org/?p=10618</guid>

					<description><![CDATA[Dr Bernard Maillere, Research director in immunology at The French Alternative Energies and Atomic Energy Commission (CEA) gave a talk that included work completed in the frame of ARDAT at the Festival of Biologics that took place 15-17 October 2024 in Basel, Switzerland. The talk title; &#8220;The localization of T cell epitopes in biopharmaceuticals : &#8230; <p class="link-more"><a href="https://ardat.org/dr-bernard-maillere-research-director-in-immunology-at-the-french-alternative-energies-and-atomic-energy-commission-cea-presented/" class="more-link">Read More <span class="screen-reader-text"> "Dr Bernard Maillere presents at The Festival of Biologics"</span></a></p>]]></description>
										<content:encoded><![CDATA[<p>Dr Bernard Maillere, Research director in immunology at The French Alternative Energies and Atomic Energy Commission (CEA) gave a talk that included work completed in the frame of ARDAT at the Festival of Biologics that took place 15-17 October 2024 in Basel, Switzerland. The talk title; &#8220;The localization of T cell epitopes in biopharmaceuticals : from peptides to gene therapy vectors.</p>
<p><img fetchpriority="high" decoding="async" class="alignnone wp-image-10619 size-full" src="https://ardat.org/wp-content/uploads/2024/12/Dr-Bernard-Maillere.jpg" alt="" width="693" height="390" srcset="https://ardat.org/wp-content/uploads/2024/12/Dr-Bernard-Maillere.jpg 693w, https://ardat.org/wp-content/uploads/2024/12/Dr-Bernard-Maillere-300x169.jpg 300w" sizes="(max-width: 693px) 100vw, 693px" /></p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
